Telephone: 612-626-2178; Fax: 612-828-4571
Embryonic Stem Cells/Induced Pluripotent Stem Cells
Version of Record online: 24 JUL 2012
Copyright © 2012 AlphaMed Press
Volume 30, Issue 8, pages 1611–1623, August 2012
How to Cite
Koyano-Nakagawa, N., Kweon, J., Iacovino, M., Shi, X., Rasmussen, T. L., Borges, L., Zirbes, K. M., Li, T., Perlingeiro, R. C. R., Kyba, M. and Garry, D. J. (2012), Etv2 Is Expressed in the Yolk Sac Hematopoietic and Endothelial Progenitors and Regulates Lmo2 Gene Expression. STEM CELLS, 30: 1611–1623. doi: 10.1002/stem.1131
Author contributions: N.K.-N.: conception and design, financial support, collection and assembly of data, data analysis and interpretation, and manuscript writing; J.K. and M.I.: conception and design, collection and assembly of data, data analysis and interpretation, and manuscript writing; X.S., T.L.R., and L.B.: conception and design, collection and assembly of data, and data analysis and interpretation; K.M.Z.: collection and assembly of data and data analysis; T.L.: data analysis and interpretation; R.C.R.P. and M.K.: provision of study material, data interpretation, and financial support; D.J.G.: conception and design, financial support, data interpretation, manuscript writing, and final approval of manuscript. N.K.-N and J.K contributed equally to this article.
Disclosure of potential conflicts of interest is found at the end of this article.
First published online in STEM CELLSEXPRESS Month 00, 2012.
- Issue online: 24 JUL 2012
- Version of Record online: 24 JUL 2012
- Accepted manuscript online: 24 MAY 2012 11:15AM EST
- Manuscript Accepted: 11 MAY 2012
- Manuscript Received: 26 SEP 2011
- National Institutes of Health. Grant Numbers: U01 HL100407, P01 GM081627, R01 HL085840, R01 HL085729
- American Heart Association
- Jon Holden DeHaan Foundation. Grant Number: 0970499
- Grant-in-Aid of Research, Artistry, and Scholarship, University of Minnesota
- Established Investigator of the American Heart Association
Additional Supporting Information may be found in the online version of this article.
|SC_11-0922_sm_supplFigure1.pdf||258K||Supplemental Figure 1. (A, B) FACS analysis of the E7.5 Etv2 WT (top) and mutant (bottom). Mutant embryos showed a decreased number of cells associated with the hematopoietic (CD41) and endothelial (Flk1) lineages in the Etv2 mutant (**: p<0.01, *: p<0.05).|
|SC_11-0922_sm_supplFigure2.pdf||636K||Supplemental Figure 2 (A) Illustration of the parasagittal sections used in this study. Mesoderm is shaded in gray. The direction of mesoderm migration within the planes of sections is indicated by red arrows 42. Note that primitive streak (PS) and node are not in a parasagittal section. (B-C) Immunohistochemistry of late streak (B) and early bud (C) stage embryos. Parasagittal sections were stained with antibodies against EYFP (green) and Pdgfra (red). Distally located EYFP+ cells coexpress Pdgfra (B, inset; arrowheads), whereas proximally located cells are negative for Pdgfra (A, inset; arrows). At the late streak stage, all EYFP+ cells are localized in developing blood islands in the yolk sac and do not colabel with Pdgfra (Am, amnion: BI, blood island: EC, exocoelomic cavity: Ecto, embryonic ectoderm: EEE, extraembryonic ectoderm: EEM, extraembryonic mesoderm: Meso, embryonic mesoderm: VE, visceral endoderm. Boxed areas are enlarged in successive panels and insets. Bars: 100 micron). (D) Blood islands in the Tie2-lacZ transgenic yolk sac in the Etv2 WT background. The section is stained for β-galactosidase activity. (E) A blood island of the Etv2 WT yolk sac stained with the Tie2 antibody. Note Tie2 signal in the endothelial and hematopoietic lineages. Arrowheads indicate the endothelial layer and asterisks denote blood.|
|SC_11-0922_sm_supplFigure3.pdf||184K||Supplemental Figure 3 qRT-PCR analysis of the E8.0 yolk sac cells. Y-axis represents relative expression level between mutant and wildtype yolk sacs (the expression of a gene in the mutant yolk sac is divided by the expression in the wildtype yolk sac).|
|SC_11-0922_sm_supplFigure4.pdf||195K||Supplemental Figure 4 Quantification of the CD41 and Tie2 positive cells after Etv2 induction from Day 3 to Day 9 in differentiated EBs [data represent an average of 3 independent experiments (bars represent SEM)].|
|SC_11-0922_sm_supplTable1.tif||2754K||Supplemental Table 1. Sequences of oligonucleotides used in the molecular analysis. The primer sequences utilized in the Lmo2 regulation studies are outlined as follows. (A) The PCR primers used for ChIP analysis where the locus is the distance from the transcriptional start site. (B) The primers for the Lmo2 +1K region that was subcloned into the luciferase reporter construct are indicated. (C) The primers for the mutagenesis of the four EBS sites in the +1K region are indicated. (D) The oligonucleotide sequences harboring the EBS3 utilized in the EMSA is provided.|
|SC_11-0922_sm_supplTable2.tif||568K||Supplemental Table 2. List of genes upregulated after 12 h of Etv2 induction in EBs at 3 days of differentiation. Genes that showed significant changes between Etv2 uninduced and induced conditions (p<0.005) are listed. Microarray data analysis was performed using three independent cultures of Etv2 inducible ES cells as described in the Methods section of the main text. False discovery rate (FDR) control was attempted using Benjamini-Hochberg method (see the last column of the table) 61, but unusual distribution of unadjusted p values resulted in extremely high FDR values estimated. An unadjusted p value cut-off of 0.005 was selected for significant differential gene expression.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.